PTCT - PTCT ALERT: Johnson Fistel Encourages Investors to Inquire About PTC Therapeutics Securities Class Action Investigation | Benzinga
SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
What if I purchased PTC securities? If you purchased securities and suffered significant losses on your investment, join our investigation now:
Click Here to Join This Action
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471
There is no cost or obligation to you.
What is Johnson Fistel investigating? On September 15, 2023, PTC ...